Name | Value |
---|---|
Revenues | 1,556.0K |
Cost of Revenue | 1,118.0K |
Gross Profit | 438.0K |
Operating Expense | 6,077.0K |
Operating I/L | -5,639.0K |
Other Income/Expense | 461.0K |
Interest Income | 461.0K |
Pretax | -5,178.0K |
Income Tax Expense | -58.0K |
Net Income/Loss | -5,178.0K |
InspireMD, Inc. specializes in the development and commercialization of its proprietary MicroNet stent platform technology for treating vascular and coronary diseases. The company's flagship products include the CGuard carotid embolic prevention system for carotid artery applications, and the MGuard Prime embolic protection systems for acute coronary syndromes and saphenous vein graft coronary interventions. Additionally, it is working on PVGuard, a MicroNet mesh sleeve and self-expandable stent for peripheral vascular applications. InspireMD generates revenue by selling these innovative medical devices through local distributors in Europe, Latin America, the Middle East, and Asia Pacific.